DORA KARIMI

Dr. DORA KARIMI

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2021 in Cancers
Verified
Journal Article
Open access
PDF file
PAPaolo G. Arduino
Paolo G. Arduino
AMAlessandro Magliano
Alessandro Magliano
AGAlessio Gambino
Alessio Gambino
AMAlessandra Macciotta
Alessandra Macciotta
MCMario Carbone
Mario Carbone
RBRoberto Broccoletti
Roberto Broccoletti
Background: Oral lichen planus (OLP) is considered an oral potentially malignant disorder. The aim of our study was to estimate the risk for oral cancer in patients diagnosed with OLP. Methods: A population-based cohort study between January 1988 and December 2020 at one hospital in Northern Italy was performed. The primary endpoint of the study was that of the histopathological diagnosis of oral cancer during the follow-up period. Results: The study population comprised 3173 patients. During the follow-up period, 32 men and 50 women developed an oral squamous cell carcinoma (2.58%), with a mean time of 103.61 months after the initial diagnosis of OLP, and 21 patients died because of oral cancer. Almost half of the deceased patients had the last follow-up visit before cancer diagnosis in a period of more than 12 months. Older age, having a red form of OLP and fewer sites of involvement, increased the risk of having cancer, while age and no treatment increased the risk of death. Conclusion: This is the largest group of OLP patients with such a long follow up ever reported. Due to the increased risk of having a malignant transformation, especially in elderly subjects, OLP patients should be regularly followed up, particularly in the Northern Italian population.

25 September 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
DKDORA KARIMI
DORA KARIMI
PAPaolo G. Arduino
Paolo G. Arduino
AGAlessio Gambino
Alessio Gambino
Francesco Maria ErovigniFrancesco Maria Erovigni
Francesco Maria Erovigni
ADAlessandro Dell’acqua
Alessandro Dell’acqua
Vittorio FuscoVittorio Fusco
Vittorio Fusco
Objectives: To assess the number of new cases of Medication-Related Osteonecrosis of the Jaw (MRONJ) among patients with osteoporosis and other non-malignant bone diseases in Northwestern Italy between 2007 and 2022. Methods: MRONJ cases were collected from referral centers in a population of 4.5 million. We analysed the number of new MRONJ cases per year, type of disease, administered drugs, duration of therapy (when available), and onset time of disease. Results: We analysed 198 cases (out of 1071 total MRONJ cases); diseases included osteoporosis (87%), rheumatoid arthritis (5%), their association (4%), Paget’s disease, and other various diseases (4%). Patients received bisphosphonates alone (74%), or denosumab alone (6%), or a sequence of different drugs (20%). The number of new cases increased over five years from 2 (2003–2007) to 51 (2008–2012), 65 (2013–2017), and 79 (2018–2022), and the percentage increased from 1% to 14%, 20%, and 29% of the total cases. Conclusions: The number of new MRONJ cases per year among patients with non-malignant diseases is rapidly increasing all around the world, though underestimation cannot be excluded. In this study, we describe epidemiological and clinical characteristics of patients, and the drug most frequently involved in MRONJ cases in our region over a long period, allowing a comprehensive view of the progression of the disease. Greater collaboration among specialists is needed for correct and early diagnosis to improve measures potentially reducing disease incidence and to limit quality of life deterioration in patients with osteoporosis and other non-malignant diseases.

1 January 2019 in Frontiers in Physiology
Verified
Journal Article
Open access
DKDORA KARIMI
DORA KARIMI
AGAlessio Gambino
Alessio Gambino
MCMarco Cabras
Marco Cabras
PAPaolo Giacomo Arduino
Paolo Giacomo Arduino
LCLuigi Chiusa
Luigi Chiusa
RBRoberto Broccoletti
Roberto Broccoletti
Aim. Oral signs and symptoms may sometimes relate to serious underlying systemic disease. Acute promyelocytic leukaemia (APL) is a subtype of acute myeloid leukaemia (AML), identified by distinctive morphology, and distinguished by a balanced reciprocal translocation between chromosomes 15 and 17. Historically, APL has been characterized by a rapidly fatal course with a high incidence of early haemorrhagic death for severe thrombocytopenia, related to a reduced bone marrow production. Such condition represents 5-15% of the AML. Symptoms are non-specific, similar to those of the other subtypes of AML (fever, asthenia, pallor, haemorrhage). The disease may be detected by a dentist if oral signs are the initial manifestation. However, reports of APL with oral involvement are very rare. The aim of this work is to present a case report of this disease which the first manifestation was in oral cavity. Materials and Methods. A 60-year-old woman with unremarkable medical history consulted her dentist for dental mobility and pain in upper right side of her mouth, present from one month; he prescribed antibiotic therapy and performed dental extractions. Three days later, the patient experienced increasing pain, poor healing, swelling and difficult in eating; therefore, one week after the extractions, the patient was referred to the Oral Medicine Section of the CIR - Dental School of Turin. At physical examination, the patient had pallor and trismus. At oral examination in the right upper edentulous ridge, there was an exophytic necrotic lesion, associated with an erosive aspect in the vestibule and in the cheek. At the palpation there was a hard and infiltrating swelling. An incisional biopsy of the lesion was then performed on the same day and at the same time blood tests were carried out and cranial CT was requested. Results. Laboratory findings showed pancytopenia (PLT 7.0x109/L; RBC 1.39x1012/L; WBC 1.65x109/L), normocytic normochromic anaemia (Hb 4.6 g/dL; MCV 94 fL; MCH 33.1 pg; MCHC 35.1 g/dL), delayed coagulation times (INR 1.19; aPTT 0.64, fibrinogen 194 mg/dL) and increased CRP at 115.7 mg/dL. Immediately the patient was sent to the emergency department, where peripheral blood smear and bone marrow sample revealed hypercellular infiltrate with 89% blast cell content with Auer rods and promyelocytic cells. Cytogenetic analysis showing genetic translocation t (15;17) further confirmed APL. Also, the pathologist's examination of oral biopsy revealed the presence of atypical promyelocytic cells and confirmed the “oral localization of Myeloid Acute Leukaemia”. The cranial CT revelated a hypodense, “honeycombed” like mass bounded by hyperdense margins. The bone cortex showed partial erosion with muscle involvement. Immediately the patient started chemotherapy and it lasted 44 days. At the end the remission was significant for the marrow and partial for the oral cavity. An oral-buccal communication remained with necrotic bone: sequestrectomy was surgically performed with the following repair of the oro-antral communication. Discussion. APL is characterized by rapid progression and usually death for haemorrhagic complications. In this case fortunately, in spite of serum levels, the patient did not experience haemorrhagic episodes. The description of this unusual presentation and the diagnostic difficulties are particularly directed toward dental practitioners to underline the importance of clinical assessment, physical examination and preoperative evaluation in clinically routine. Several haematological diseases could have as first oral manifestation and, in these cases, dentists are the oral physicians that can suspect it and they must refer patient to a haematologist.